Panagiotis Kokkoris

656 total citations
17 papers, 443 citations indexed

About

Panagiotis Kokkoris is a scholar working on Oncology, Orthopedics and Sports Medicine and Molecular Biology. According to data from OpenAlex, Panagiotis Kokkoris has authored 17 papers receiving a total of 443 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 6 papers in Orthopedics and Sports Medicine and 4 papers in Molecular Biology. Recurrent topics in Panagiotis Kokkoris's work include Bone health and treatments (6 papers), Bone health and osteoporosis research (6 papers) and Adrenal Hormones and Disorders (3 papers). Panagiotis Kokkoris is often cited by papers focused on Bone health and treatments (6 papers), Bone health and osteoporosis research (6 papers) and Adrenal Hormones and Disorders (3 papers). Panagiotis Kokkoris collaborates with scholars based in Greece, Australia and United States. Panagiotis Kokkoris's co-authors include F. Xavier Pi‐Sunyer, Polyzois Makras, Αθανάσιος Παπαθεοδώρου, Athanasios D. Anastasilakis, Stergios A. Pοlyzos, N. Thalassinos, C.C. Alevizaki, G Sakellariou, Vasilis Vasiliou and Evangelos Terpos and has published in prestigious journals such as Bone, Metabolism and Osteoporosis International.

In The Last Decade

Panagiotis Kokkoris

17 papers receiving 423 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Panagiotis Kokkoris Greece 11 175 138 121 115 91 17 443
Makoto Takizawa Japan 11 94 0.5× 144 1.0× 172 1.4× 190 1.7× 243 2.7× 20 515
Peter Papapetrou Greece 9 158 0.9× 71 0.5× 229 1.9× 197 1.7× 108 1.2× 23 601
Norman Heyden United States 7 62 0.4× 66 0.5× 164 1.4× 177 1.5× 126 1.4× 8 498
M. D’Herbomez France 17 391 2.2× 178 1.3× 103 0.9× 88 0.8× 116 1.3× 47 699
Nicky Kelepouris United States 10 242 1.4× 81 0.6× 138 1.1× 177 1.5× 137 1.5× 31 569
Constantinos Panoulis Greece 16 174 1.0× 62 0.4× 70 0.6× 49 0.4× 67 0.7× 82 530
A. M. McGregor United Kingdom 15 384 2.2× 54 0.4× 138 1.1× 72 0.6× 176 1.9× 21 673
Claudia Campusano Chile 11 104 0.6× 78 0.6× 42 0.3× 80 0.7× 83 0.9× 41 323
Larisa Dzeranova Russia 13 273 1.6× 127 0.9× 73 0.6× 105 0.9× 68 0.7× 133 585
Spyridon Gerou Greece 10 57 0.3× 68 0.5× 121 1.0× 106 0.9× 147 1.6× 31 393

Countries citing papers authored by Panagiotis Kokkoris

Since Specialization
Citations

This map shows the geographic impact of Panagiotis Kokkoris's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Panagiotis Kokkoris with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Panagiotis Kokkoris more than expected).

Fields of papers citing papers by Panagiotis Kokkoris

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Panagiotis Kokkoris. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Panagiotis Kokkoris. The network helps show where Panagiotis Kokkoris may publish in the future.

Co-authorship network of co-authors of Panagiotis Kokkoris

This figure shows the co-authorship network connecting the top 25 collaborators of Panagiotis Kokkoris. A scholar is included among the top collaborators of Panagiotis Kokkoris based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Panagiotis Kokkoris. Panagiotis Kokkoris is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Trovas, George, Νικόλαος Παπαϊωάννου, Polyzois Makras, et al.. (2018). Serum 25-hydroxyvitamin D status, quantitative ultrasound parameters, and their determinants in Greek population. Archives of Osteoporosis. 13(1). 111–111. 13 indexed citations
2.
Anastasilakis, Athanasios D., Stergios A. Pοlyzos, Marina Tsoli, et al.. (2017). Low periostin levels in adult patients with Langerhans cell histiocytosis are independently associated with the disease activity. Metabolism. 71. 198–201. 2 indexed citations
3.
Terpos, Evangelos, D. Christoulas, Efstathios Kastritis, et al.. (2016). High levels of periostin correlate with increased fracture rate, diffuse MRI pattern, abnormal bone remodeling and advanced disease stage in patients with newly diagnosed symptomatic multiple myeloma. Blood Cancer Journal. 6(10). e482–e482. 13 indexed citations
4.
Kokkoris, Panagiotis, et al.. (2016). Bone density in the HIP and the lumbar spine in healthy male population. Endocrine Abstracts. 1 indexed citations
5.
Pοlyzos, Stergios A., Athanasios D. Anastasilakis, Јannis Kountouras, et al.. (2015). Circulating sclerostin and Dickkopf-1 levels in patients with nonalcoholic fatty liver disease. Journal of Bone and Mineral Metabolism. 34(4). 447–456. 24 indexed citations
6.
Anastasilakis, Athanasios D., Stergios A. Pοlyzos, Zoe Efstathiadou, et al.. (2015). Denosumab in treatment-naïve and pre-treated with zoledronic acid postmenopausal women with low bone mass: Effect on bone mineral density and bone turnover markers. Metabolism. 64(10). 1291–1297. 24 indexed citations
7.
Anastasilakis, Athanasios D., Stergios A. Pοlyzos, Athina Gkiomisi, et al.. (2015). Denosumab versus zoledronic acid in patients previously treated with zoledronic acid. Osteoporosis International. 26(10). 2521–2527. 48 indexed citations
8.
Anastasilakis, Athanasios D., Stergios A. Pοlyzos, Polyzois Makras, et al.. (2014). Circulating semaphorin-4D and plexin-B1 levels in postmenopausal women with low bone mass: the 3-month effect of zoledronic acid, denosumab or teriparatide treatment. Expert Opinion on Therapeutic Targets. 19(3). 299–306. 16 indexed citations
9.
Maniotis, Christos, Panagiotis Kokkoris, Dimitrios Papadogiannis, et al.. (2014). The AGT and the GNB3 polymorphisms and insulin resistance in prehypertension. HORMONES. 13(1). 79–86. 4 indexed citations
10.
Makras, Polyzois, et al.. (2013). Parathyroid hormone changes following denosumab treatment in postmenopausal osteoporosis. Clinical Endocrinology. 79(4). 499–503. 46 indexed citations
11.
Makras, Polyzois, Evangelos Terpos, George Kanakis, et al.. (2011). Reduced bone mineral density in adult patients with Langerhans cell histiocytosis. Pediatric Blood & Cancer. 58(5). 819–822. 13 indexed citations
12.
Anargyrou, Konstantinos, T. P. Vassilakopoulos, Konstantinos Tsionos, et al.. (2011). Low bone mineral density and high bone turnover in patients with non-Hodgkin's lymphoma (NHL) who receive frontline therapy: Results of a multicenter prospective study. Bone. 48. S254–S255. 1 indexed citations
13.
Makras, Polyzois & Panagiotis Kokkoris. (2010). A 41-year-old man with a vertebral fracture and bone marrow mastocytosis.. PubMed. 10(4). 290–2. 1 indexed citations
14.
Kokkoris, Panagiotis & F. Xavier Pi‐Sunyer. (2003). Obesity and endocrine disease. Endocrinology and Metabolism Clinics of North America. 32(4). 895–914. 115 indexed citations
15.
Tsagarakis, Stylianos, et al.. (2000). The application of a combined stimulation with CRH and desmopressin during bilateral inferior petrosal sinus sampling in patients with Cushing's syndrome. Clinical Endocrinology. 52(3). 355–361. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026